Pay in 4 interest-free payments of $5.82 Learn more
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
GLP-1R CNS expression confirmed in humans Nature Metabolism Safety Data Safety Profile from Research What preclinical and early clinical studies report Preclinical Safety Summary GI toleranceBetter than GLP-1 mono at equivalent doses (preclinical) Hypoglycemia riskLow glucose-dependent insulin release Organ toxicityNone observed in preclinical models GLP-1 safety classWell-established class safety profile Receptor bindingBalanced affinity no single-receptor overdominance Regulatory & Risk Considerations FDA statusUnapproved research use only GI effectsNausea, vomiting (class effect) possible PancreatitisTheoretical GLP-1 class risk Heart rateMild elevation (glucagon component) Long-term effectsUnknown novel triple combination Cancer riskTheoretical thyroid C-cell risk (GLP-1 class, rodents only) The triple agonist approach (GLP-1R + GIPR + GcgR) is the frontier of metabolic peptide research
Traditional food innovation cycles werent designed to move at that pace
From there, Ill also point you toward additional learning including: Practical strategies for reducing visceral fat How to avoid pharmaceuticals that may contribute to muscle loss A concept I call the binge snowball . As a moment of transparency, Id love to make all of my content 100% free and available to everyone
For rare, severe or worsening symptoms, we recommend you seek professional medical advice
DunhamSnary Endocrinology, Diabetes & Metabolism .2025;[Epub] CrossRef Liver Transplantation in the Era of Metabolic DysfunctionAssociated Fatty Liver Disease: Challenges, Ethical Dilemmas, and Future Directions Said A
US$ 21.58
US$ 27.27
US$ 22.30
